CPRIT Oversight Committee Meeting (May 17, 2023)
(AUSTIN) The governing board of the Cancer Prevention and Research Institute of Texas (CPRIT) advanced the fight against cancer by approving over $73 million in new cancer research grants at its quarterly meeting on Wednesday.
The board approved $60 million in crucial, early-stage investments in Texas-based companies developing breakthrough cancer-fighting drugs and treatments, including one company relocating from Seattle to Houston. The Oversight Committee also approved several new CPRIT scholar awards to recruit world-class cancer investigators from across the country to Texas institutions.